EXPRESSION/REGULATION OF PHOSPHODIESTERASE 3 ISOFORMS
磷酸二酯酶 3 异构体的表达/调节
基本信息
- 批准号:6162715
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:3'5' cyclic nucleotide phosphodiesterase B lymphocyte T lymphocyte cell differentiation cell type enzyme activity esterase inhibitor gene targeting in situ hybridization inflammation isozymes laboratory mouse laboratory rat leukocyte activation /transformation macrophage natural killer cells northern blottings protein isoforms transfection
项目摘要
By catalyzing hydrolysis of cAMP and cGMP, cyclic nucleotide
phosphodiesterases (PDEs) are critical regulators of intracellular
concentrations of, and biological responses mediated by, cyclic
nucleotides, including immune/in- flammatory responses. Understanding
cellular regulation of PDE isoforms [which belong to seven gene families
(PDE1-7)] will be of increasing importance for targeting specific PDEs
in treating pulmonary disorders. Although individual cells usually
contain representatives of several PDE gene families, little is known
of signalling pathways involved in cytokine and growth factor regulation
of different PDEs in a single cell. Incubation of FDCP-2 myeloid cells
with Interleukin-4 (IL-4) increased both PDE3 and PDE4 activities,
whereas IL-3, Granulocyte/Macrophage Colony Stimulating Factor (GMCSF)
and phorbol ester (PMA) increased PDE4 only. IL-4 (not IL-3, GMCSF, PMA)
induced rapid tyrosine phosphorylation of Insulin-receptor Substrate-2
(IRS-2 is a docking protein which functions to localize and coordinate
interactions between receptors and signalling molecules/complexes).
IL-4 induced activation of PDE3, PDE4 and the downstream protein
kinases, mitogen-activated kinase (MAPK) and PKB, (but not IL-4 induced
phosphorylation of STAT-5) were blocked by Tumor Necrosis Factor alpha
(TNFalpha) which reduced IL-4-induced tyrosine phosphorylation of IRS-2
and its association with phosphatidylinositol 3-kinase (PI3-K) and by
wortmannin, a PI3-K inhibitor. Downstream of PI3-K, IL-4 signals
diverge, with PDE3 regulated by MAPK-independent and PDE4 by
MAPK-dependent pathways. IL-3, GMCSF, and PMA also regulate PDE4 by
MAPK dependent pathways. Whereas IL-3 induced activation of MAPK may
be mediated by PI3-K (independent of IRS-2 signals) the effect of PMA
is dependent on Protein kinase C signals. Thus, PDE4 may be regulated
by MAPK activated by different mechanisms, i.e., IRS-2/PI3-K (IL-4),
PI3-K ( IL-3, GMCSF) and Protein kinase C (PMA). It is possible that
IRS-2 is intimately involved in IL-4 induced activation of PDE3, perhaps
by initiating a specific set of signals or by targeting a specific
signalling complex to PDE3. Although PDE4 is thought to be the
predominant PDE isoform in most inflammatory/immune cells, PDE3 and
PDE4, which exhibit a high affinity for cAMP, are both present in
lymphocytes and macrophages. However, the proportion of PDE4 relative
to PDE3 was greater in T-cells infected with the human T-cell
leukemia/lymphotropic virus Type I (HTLV-1) than in other T cell-derived
cells, including cells infected with the related retrovirus HTLV-2, NK
lymphocytes, Kit and Jurkat leukemia cell lines, CD4+ T-cell clones
specific sensitized to myelin basic protein. Incubation of some, but
not all, HTLV-1 infected cell lines with the scr-kinase inhibitor
herbimycin dramatically reduced PDE activity; the mechanism(s) and
significance of this differential inhibition by herbimycin is not
understood. After 5-7 days in culture elutriated peripheral human
monocytes adhere to plastic surfaces and increase dramatically in size.
The morphologic change is accompanied by a relative increase in PDE3B
mRNA and activity, Glut 5 transporter and PDE1C mRNAs and a relative
decrease in PDE4 activity and PDE4B mRNA. It will be important to
define specific PDE isoforms present in alveolar macrophages and to
determine if cellular inflammatory responses can be altered by PDE
inhibitors.
通过催化CAMP和CGMP的水解,环状核苷酸
磷酸二酯酶(PDE)是细胞内的关键调节剂
循环介导的浓度和生物反应的浓度和生物反应
核苷酸,包括免疫/燃料反应。 理解
PDE同工型的细胞调节[属于七个基因家族
(PDE1-7)]对靶向特定PDE的重要性将增加
治疗肺部疾病。 尽管单个细胞通常
包含几个PDE基因家族的代表,鲜为人知
涉及细胞因子和生长因子调节的信号通路
单个单元格中不同的PDE。 孵育FDCP-2髓样细胞
随着白介素-4(IL-4)的增加,PDE3和PDE4活性都增加了,
而IL-3,粒细胞/巨噬细胞刺激因子(GMCSF)
和佛波酯(PMA)仅增加PDE4。 IL-4(不是IL-3,GMCSF,PMA)
胰岛素受体底物-2的诱导快速酪氨酸磷酸化
(IRS-2是一种对接蛋白,其作用可定位和坐标
受体与信号分子/复合物之间的相互作用)。
IL-4诱导的PDE3,PDE4和下游蛋白的激活
激酶,有丝分裂原激活激酶(MAPK)和PKB(但未诱导IL-4
Stat-5的磷酸化被肿瘤坏死因子alpha阻断
(tnfalpha)降低了IRS-2的IL-4诱导的酪氨酸磷酸化
及其与磷脂酰肌醇3-激酶(PI3-K)的关联
Wortmannin,PI3-K抑制剂。 PI3-K,IL-4信号的下游
分歧,由由MAPK独立和PDE4调节的PDE3由
MAPK依赖性途径。 IL-3,GMCSF和PMA也通过
MAPK依赖途径。 而IL-3诱导的MAPK激活可能
由PI3-K(独立于IRS-2信号)介导PMA的效果
取决于蛋白激酶C信号。因此,可以调节PDE4
由MAPK被不同的机制激活,即IRS-2/PI3-K(IL-4),
PI3-K(IL-3,GMCSF)和蛋白激酶C(PMA)。 有可能
IRS-2与IL-4诱导的PDE3激活密切相关,也许
通过启动一组特定的信号或针对特定的信号
信号复合物至PDE3。 虽然PDE4被认为是
在大多数炎症/免疫细胞中,PDE3和PDE3和
对营地表现出高亲和力的PDE4都存在
淋巴细胞和巨噬细胞。 但是,PDE4相对的比例
在被人类T细胞感染的T细胞中,PDE3更大
与其他T细胞衍生的白血病/淋巴病毒I型(HTLV-1)
细胞,包括感染相关逆转录病毒HTLV-2,NK的细胞
淋巴细胞,套件和Jurkat白血病细胞系,CD4+ T细胞克隆
特异性对髓磷脂碱性蛋白质敏感。 孵化一些,但是
并非全部,HTLV-1感染了SCR-激酶抑制剂的细胞系
除草霉素大大降低了PDE活性;机制和
除草剂抑制这种差异的意义不是
理解。 5-7天后,培养的外围人类
单核细胞粘附在塑料表面并大小急剧增加。
形态变化伴随着PDE3B的相对增加
mRNA和活性,Glut 5转运蛋白和PDE1C mRNA以及相对
PDE4活性和PDE4B mRNA的降低。 重要的是
定义肺泡巨噬细胞中存在的特定PDE同工型
确定PDE是否可以改变细胞炎症反应
抑制剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
V MANGANIELLO其他文献
V MANGANIELLO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('V MANGANIELLO', 18)}}的其他基金
EXPRESSION/REGULATION OF PHOSPHODIESTERASE 3 ISOFORMS
磷酸二酯酶 3 异构体的表达/调节
- 批准号:
2576804 - 财政年份:
- 资助金额:
-- - 项目类别:
相似国自然基金
ISG15+ B淋巴细胞通过与PD-1+CXCR5−CD4+ Th-CXCL13 T细胞相互作用介导三级淋巴结构的形成和成熟以促进复发转移鼻咽癌免疫联合抗血管治疗响应的作用及机制研究
- 批准号:82373258
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于大数据的T/B双表型急性淋巴细胞白血病研究
- 批准号:82270159
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
铁蛋白的定向改构及其用于增强CAR-T细胞治疗B系急性淋巴细胞白血病的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基因工程敲减IL-6/CD40L的CAR-T细胞在复发/难治性急性B淋巴细胞白血病治疗中提高安全性的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肿瘤细胞表达的B7-H3通过抑制效应T淋巴细胞介导卵巢癌免疫逃逸的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Expression, Structure/function And Regulation Of Phospho
Phospho的表达、结构/功能和调控
- 批准号:
6671694 - 财政年份:
- 资助金额:
-- - 项目类别:
Expression, Structure/function And Regulation Of Phospho
Phospho的表达、结构/功能和调控
- 批准号:
6809653 - 财政年份:
- 资助金额:
-- - 项目类别:
EXPRESSION/REGULATION OF PHOSPHODIESTERASE 3 ISOFORMS
磷酸二酯酶 3 异构体的表达/调节
- 批准号:
6432692 - 财政年份:
- 资助金额:
-- - 项目类别:
EXPRESSION/REGULATION OF PHOSPHODIESTERASE 3 ISOFORMS
磷酸二酯酶 3 异构体的表达/调节
- 批准号:
6290429 - 财政年份:
- 资助金额:
-- - 项目类别:
Expression, Structure/function And Regulation Of Phospho
Phospho的表达、结构/功能和调控
- 批准号:
6541694 - 财政年份:
- 资助金额:
-- - 项目类别: